Jaromir Hacek

Prague, PR, Czech Republic

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Identification of alpha1-oleate as a potent regulator of adipokine-dependent metabolism, in bladder cancer tissue.

Identification of alpha1-oleate as a potent regulator of adipokine-dependent metabolism, in bladder cancer tissue.

Journal: Cancer & metabolism

Published: December 22, 2025

Enterohemorrhagic Escherichia coli O157 outer membrane vesicles administered by oral gavage cause renal tubular injury and acute kidney failure in mice.

Enterohemorrhagic Escherichia coli O157 outer membrane vesicles administered by oral gavage cause renal tubular injury and acute kidney failure in mice.

Journal: Frontiers in cellular and infection microbiology

Published: September 13, 2025

A case series of newly described rare mesenchymal tumors of the knee and the role of molecular testing in their histopathological diagnosis.

A case series of newly described rare mesenchymal tumors of the knee and the role of molecular testing in their histopathological diagnosis.

Journal: Pathology, research and practice

Published: July 07, 2025

Towards Defining Follow-up Strategies for Patients with Primary Intermediate-risk Non-muscle-invasive Bladder Cancer.

Towards Defining Follow-up Strategies for Patients with Primary Intermediate-risk Non-muscle-invasive Bladder Cancer.

Journal: European urology oncology

Published: December 02, 2024

Clinical and molecular response to alpha1-oleate treatment in patients with bladder cancer.

Clinical and molecular response to alpha1-oleate treatment in patients with bladder cancer.

Journal: Cancer medicine

Published: February 29, 2024

Similar immune responses to alpha1-oleate and Bacillus Calmette-Guérin treatment in patients with bladder cancer.

Similar immune responses to alpha1-oleate and Bacillus Calmette-Guérin treatment in patients with bladder cancer.

Journal: Cancer medicine

Published: December 07, 2023

BAMLET administration via drinking water inhibits intestinal tumor development and promotes long-term health.

BAMLET administration via drinking water inhibits intestinal tumor development and promotes long-term health.

Journal: Scientific reports

Published: November 07, 2023

Second TURB, restaging TURB or repeat TURB in primary T1 non-muscle invasive bladder cancer: impact on prognosis?

Second TURB, restaging TURB or repeat TURB in primary T1 non-muscle invasive bladder cancer: impact on prognosis?

Journal: International urology and nephrology

Published: October 12, 2023

Intravesical thermochemotherapy in the treatment of high-risk and very high-risk non-muscle-invasive urothelial bladder cancer: a single-arm study.

Intravesical thermochemotherapy in the treatment of high-risk and very high-risk non-muscle-invasive urothelial bladder cancer: a single-arm study.

Journal: International urology and nephrology

Published: September 14, 2023

Distinct leukocyte populations and cytokine secretion profiles define tumoral and peritumoral areas in renal cell carcinoma.

Distinct leukocyte populations and cytokine secretion profiles define tumoral and peritumoral areas in renal cell carcinoma.

Journal: Translational oncology

Published: July 11, 2023

Erratum to "European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel" [Eur. Urol. 79(4) (2021) 480-488].

Erratum to "European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel" [Eur. Urol. 79(4) (2021) 480-488].

Journal: European urology

Published: February 25, 2023

Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive Spectrum.

Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive Spectrum.

Journal: European urology oncology

Published: August 23, 2022

Showing 1-12 of 37

Last Updated: 09/26/2026